The clamp-like index: A novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects

Diabetes Care

Volumn 30, Issue 9, 2007, Pages 2374-2380

  Anderwald, Christian ^a   Anderwald Stadler, Marietta ^b   Promintzer, Miriam ^a   Prager, Gerhard ^a   Mandl, Martina ^a   Nowotny, Peter ^a   Bischof, Martin G ^a   Wolzt, Michael ^a   Ludvik, Bernhard ^a   Kästenbauer, Thomas ^b   Pacini, Giovanni ^c   Luger, Anton ^a   Krebs, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hietzing Hospital   (Austria)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MATHEMATICAL MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHARMACEUTICAL SOLUTIONS;

EID: 34548391880     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0422     Document Type: Article

References (35)

1. Anderwald C, Roden M: Adipotoxicity and the insulin resistance syndrome. Pediatr Endocrinol Rev 1:310-319, 2004
2. Ferrannini E: Is insulin resistance the cause of the metabolic syndrome? Ann Med 38:42-51, 2006
3. Magliano DJ, Shaw JE, Zimmet PZ: How to best define the metabolic syndrome. Ann Med 38:34-41, 2006
4. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915, 1990
5. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997
6. Goldfine AB, Bouche C, Parker RA, Kim C, Kerivan A, Soeldner JS, Martin BC, Warram JH, Kahn CR: Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A 100:2724-2729, 2003
7. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100:1166-1173, 1997
8. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
9. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548, 2001
10. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301, 2000
11. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470, 1999
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
13. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410, 2000
14. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y: Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab 87:5332-5335, 2002
15. Pacini G, Mari A: Methods for clinical assessment of insulin sensitivity and betacell function. Best Pract Res Clin Endocrinol Metab 17:305-322, 2003
16. Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R: Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: a sign of impaired β-cell function? Diabetes Care 29:1031-1038, 2006
17. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753-759, 2007
18. Anderwald C, Bernroider E, Krššák M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W: Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscles. Diabetes 51:3025-3032, 2002
19. Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhäusl W, Roden M: Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52:1792-1798, 2003
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, the Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-470, 1999
21. Bokemark L, Froden A, Attvall S, Wikstrand J, Fagerberg B: The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest 60:27-36, 2000
22. Reed AH, Henry RJ, Mason WB: Influence of statistical method used on the resulting estimate of normal range. Clin Chem 17:275-284, 1971
23. McSorley PT, Bell PM, Young IS, Atkinson AB, Sheridan B, Fee JP, McCance DR: Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med 22:703-710, 2005
24. Elbein SC: The genetics of human noninsulin-dependent (type 2) diabetes mellitus. J Nutr 127:1891S-1896S, 1997
25. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA: Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55:1430-1435, 2006
26. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A: Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 88:1019-1023, 2003
27. Katz AI, Rubenstein AH: Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest 52:1113-1121, 1973
28. Imamura Y, Yokono K, Shii K, Hari J, Sakai H, Baba S: Plasma levels of proinsulin, insulin and C-peptide in chronic renal, hepatic and muscular disorders. Jpn J Med 23:3-8, 1984
29. Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kuzuya H, Horwitz DL, Rubenstein AH, Rossing N: Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62:197-203, 1978
30. Tompkins CV, Srivastava MC, Sonksen PH, Nabarro JD: A comparative study of the distribution and metabolism of mono-component human insulin and porcine proinsulin in man. Biochem J 125:64P, 1971
31. Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R: A model of the kinetics of insulin in man. J Clin Invest 53:1481-1492, 1974
32. Insel PA, Liljenquist JE, Tobin JD, Sherwin RS, Watkins P, Andres R, Berman M: Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest 55:1057-1066, 1975
33. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG: Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol 51: 762-766, 1981
34. Krebs M, Krššák M, Nowotny P, Weghuber D, Gruber S, Mlynarik V, Bischof M, Stingl H, Fürnsinn C, Waldhäusl W, Roden M: Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 86:2153-2160, 2001
35. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A, Walker M, Ferrannini E, EGIR-RISC Study Group: The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk). I. Methodology and objectives. Diabetologia 47:566-570, 2004